Bone Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

02.02.16	Bone Therapeutics Extends Kasios Collaboration (Businesswire)
18.01.16	Bone Therapeutics Expands Its Delayed-Union Program with ALLOB® into Multiple Fractures (Businesswire)
05.01.16	Bone Therapeutics Granted an Additional EUR 2 Million in Non-Dilutive Funding by the Walloon Region (Businesswire)
23.12.15	Bone Therapeutics Announces Its Financial Calendar for 2016 (Businesswire)
15.12.15	Bone Therapeutics Completes Recruitment of the First Half of Patients in ALLOB® Phase IIA Spinal Fusion Trial (Businesswire)
11.12.15	Bone Therapeutics: ALLOB® Delayed-Union Program Awarded at Cells Orthopedics Conference (Businesswire)
30.11.15	Bone Therapeutics Awarded EUR 3 million in Funding to Support New Research Projects (Businesswire)
18.11.15	Bone Therapeutics Provides Business Update for the Third Quarter of 2015 (Businesswire)
12.11.15	Bone Therapeutics’ ALLOB® receives Orphan Drug Designation for Osteogenesis Imperfecta from the EMA and FDA (Businesswire)
09.11.15	Bone Therapeutics Appoints Thomas Lienard as Chief Business Officer (Businesswire)
22.10.15	Bone Therapeutics: Transparency Notification Received From S.R.I.W. SA & Sofipôle SA (Businesswire)
13.10.15	Bone Therapeutics to Participate in Key Investor Conferences in Q4 2015 (Businesswire)
28.09.15	Bone Therapeutics Treats First Patients in Pioneering Trial for Minimally Invasive Treatment of Failed Spinal Fusion (Businesswire)
22.09.15	Bone Therapeutics Announces Half-Year Results for 2015 (Businesswire)
21.09.15	Bone Therapeutics Notice of Half Year Results 2015 (Businesswire)
03.08.15	Bone Therapeutics Appoints Bank Degroof as Liquidity Provider (Businesswire)
22.06.15	Bone Therapeutics Reports First Results of Its Phase IIA Trial for PREOB® in Severe Osteoporosis (Businesswire)
15.05.15	Bone Therapeutics Provides Business Update for the First Quarter 2015 (Businesswire)
28.04.15	Bone Therapeutics: The Preparatory Documents for the Annual General Shareholder Meeting on 28 May 2015 Have Been Made Available (Businesswire)
28.04.15	Bone Therapeutics Reports 2014 Financial and Operational Results (Businesswire)
24.04.15	Bone Therapeutics Officially Opens Its New Headquarters in Gosselies (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Bone Therapeutics S.A.

Aktien Top/Flop

Meistgelesene Nachrichten